Parisa Momtaz
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses
Most-Cited Works
- → Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer(2023)1,154 cited
- → Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center(2015)1,065 cited
- → First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial(2020)349 cited
- → Neoadjuvant relatlimab and nivolumab in resectable melanoma(2022)317 cited
- → Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial(2010)231 cited
- → Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis(2016)199 cited
- → Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade(2020)189 cited
- → RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer(2025)187 cited
- → Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma(2017)162 cited
- → Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment(2003)146 cited